Not checkedNot checked for notices yet.
Epidemiology and antifungal resistance in invasive aspergillosis according to primary disease - review of the literature
Mayr A, Lass-Flörl C
European Journal of Medical Research · 2011
doi:10.1186/2047-783x-16-4-153 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
<p>Abstract</p> <p>Aspergilli, less susceptible to antifungals emerge and resistance to azoles have been found mainly in <it>Aspergillus fumigatus; </it>this has launched a new phase in handling aspergillosis. Resistant strains have currently been reported from Belgium, Canada, China, Denmark, France, Norway, Spain, Sweden, The Netherlands, UK and the USA. Centres in the UK (Manchester) and The Netherlands (Nijmegen) have described particularly high frequencies (15 and 10% respectively), and a significant increase in azole resistance in recent years. The reason of this high incidence may be due to long term azole therapy in patients with chronic aspergillosis in Manchester, and due to high use of agricultural azoles in Nijmegen. The primary underlying mechanism of resistance is as a result of alterations in the <it>cyp51A </it>target gene, with a variety of mutations found in clinical isolates and one genotype identified in the environmental (LH98). Reports on well documented in vitro and in vivo resistance to echinocandins are rare for <it>Aspergillus </it>species and resistance may be under-diagnosed as susceptibility testing is less frequently performed due to technical reasons.</p>
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.